Cytovia Therapeutics Acquires Worldwide Rights to CytoImmune Therapeutics’ First-In-Class EGFR Dual-targeting CAR for NK Cell Treatment of Glioblastoma & Other Solid Tumors

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Stacey Gandler
Brand Nourishment

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Brenda Snow
Authentic Patient Voice